Evidence map›Paper›PMID 20136845›Full record

ArticleBritish journal of pharmacology2010

The COX-2 inhibitors, meloxicam and nimesulide, suppress neurogenesis in the adult mouse brain.

Maria Beatriz Goncalves, Emma-Jane Williams, Ping Yip, Rafael J Yáñez-Muñoz, Gareth Williams, Patrick Doherty

Open access · greenAbstract read
In one paragraph

Article in British journal of pharmacology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Update on the pathological roles of prostaglandin ETranslational neurodegeneration · 2023
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy.Biochimica et biophysica acta. Molecular basis of disease · 2017
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Maria Beatriz GoncalvesWolfson Centre for Age-related Diseases, King's College, London, UK.
Emma-Jane Williams
Ping Yip
Rafael J Yáñez-Muñoz
Gareth Williams
Patrick Doherty
King's College London · GBRoyal Holloway University of London · GB

Funding

Biotechnology and Biological Sciences Research Council
6 · The paper itself

Abstract

background and purposeIn adults, neurogenesis persists in the hippocampus and the subventricular zone (SVZ), and this is important for learning and memory. Inhibitors of COX-2 suppress ischaemia-induced neurogenesis in the hippocampus. Here, we have determined the effects of COX-2 inhibitors on neurogenesis throughout the normal adult mouse brain. EXPERIMENTAL APPROACH: Young adult mice were treated with COX-2 inhibitors, and the proliferation of neural progenitor cells was measured in the SVZ and hippocampus. In addition, the local uptake of lentiviral vectors in the rostral migratory stream enabled the formation of new neurons in the olfactory bulb (OB) to be assessed. KEY

resultsThe COX-2 inhibitor meloxicam suppressed progenitor cell proliferation in the SVZ and hippocampus. A significant decrease in the appearance of new neurons in the OB was also observed. Similar effects on progenitor proliferation in the SVZ were seen with nimesulide. The absence of COX-2 expression in the proliferating progenitors in vivo, and the lack of effect of the COX-2 inhibitors on the growth rate of a cultured progenitor cell line, suggest that the effect is indirect. The specific expression of COX-2 in resting microglia that closely associate with the proliferating progenitor cells provides for a possible site of action. CONCLUSIONS AND IMPLICATIONS: Treatment with a COX-2 inhibitor results in a substantial inhibition of adult neurogenesis. Studies on human tissues are warranted in order to determine if this effect extends to humans, and whether inhibition of neurogenesis should be considered as an adverse effect of these drugs.

Indexed as

AnimalsBrainCell ProliferationCyclooxygenase 2Cyclooxygenase 2 InhibitorsFemaleGene Expression Regulation, EnzymologicMeloxicamMiceMice, Inbred C57BLNeurogenesisNeuronsStem CellsSulfonamidesThiazinesThiazolesCyclooxygenase 2Cyclooxygenase 2 InhibitorsMeloxicamnimesulideSulfonamidesThiazinesThiazoles

Identifiers

PMID20136845
PMCPMC2839269
OpenAlexW1487241194

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.